期刊文献+

基于基因及心理因素的曲马多药效模型的研究

Study on a predictive model for tramadol response from genetic and psychological factors
原文传递
导出
摘要 目的:综合患者抑郁、焦虑水平及CYP2D6,P-gp,OPRM1,COMT位点基因多态性共六因素建立曲马多有效性的预测模型。方法:共入组250例,分为A组(200例)和B组(50例),均为在南京某医院进行上肢骨折内固定手术的患者,术前一晚进行心理评估,采用连接酶检测反应(LDR)对CYP2D6,P-gp,OPRM1,COMT进行基因检测。A组实验数据采用二元logistic回归得出预测模型;用非参数检验方法将B组患者的实验数据用于预测模型的检验。结果:根据A组数据得出预测模型:Logit(1)=2.304-4.841×(焦虑Ⅰ)-23.709×(焦虑II)+2.823×(P-gp 3435 CT)+5.737×(P-gp 3435 TT)-1.586×(CYP2D6×10 CT)-4.542×(CYP2D6×10 TT)。模型的阳性预测率为90%。将模型应用于B组患者,得出模型的阳性预测率为86%。回归方程的拟合优度Nagelkerke R2为0.819,Hosmer和Lemeshow检验结果为0.981。非参数检验结果显示B组患者的曲马多实际药效与模型预测药效结果没有显著差异(P=0.083)。结论:本项研究结果可能是有效预测曲马多药效的潜在模型。 OBJECTIVE To develop an algorithm by polymorphisms of CYP2D6, P-gp, OPRM1, COMT and psychological variables to predict tramadol response in Chinese patients. METHODS A total of 250 Han Chinese patients recovering from fracture in upper limb were enrolled. Psychological tests were conducted the night before surgery, and CYP2D6×10, PgpG2677T, P-gp C3435T, OPRM1 A118G and COMT Va1158Met were detected by ligase detection reaction (LDR) method. The algorittun was developed with binary logistic regression in cohort 1 (200 patients) and assessed with Wilcoxon signed-rank test in cohort 2 (50 patients), liF^ULI'S According to cohort 1, the predictive equation was calculated with the following logistic regression parameters: Logit(1) = 2. 304 - 4. 841 × (anxiety I ) - 23. 709 × (anxiety Ⅱ ) + 2. 823 × (P-gp 3435 CT) + 5. 737 × (p-gp 3435 TT) - 1. 586 x (CYP2D6 × 10 CT) -4. 542 × (CYP2D6 × 10 TT). The equation's positive predictive value (PPV) was 900/00. When applied to cohort 2, the PPV was 86%. The Nagelkerke R2 of the model was 0. 819, and the Hosmer and Lemeshow test value was 0. 981. Wilcoxon signed-rank test displayed that there was no significant difference between the actual response and predicted one (P = 0. 083). CONCLUSION The algorithm developed by us might predict tramadol response in Chinese patients.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第14期1184-1188,共5页 Chinese Journal of Hospital Pharmacy
基金 南京市卫生局医学科技发展基金(YKK12086)
关键词 曲马多药效 中国患者 基因多态性 疼痛 tramadol response Chinese patients pharmacogenetics pain
  • 相关文献

参考文献30

  • 1Neugebauer EA, Wilkinson RC, Kehlet H, et al. PROS- PECT: a practical method for formulating evidence based ex pert recommendations for the management of postoperative pain[J]. Surg Endosc,2007, 21(7) : 1047-11)53.
  • 2陈军杰.氯诺昔康复合曲马多应用于腹部术后镇痛的疗效观察[J].中国医院药学杂志,2012,32(9):717-719. 被引量:4
  • 3Mette L, Mitropoulos K, Vozikes A, et al. Pharmacogenom- ics and public health: implementing "populationalized" medicine [J]. Pharmacogenomics, 2012,13(7) ; 803 -813.
  • 4Baliki MN, Chialvo DR, Geha PY, et al. Chronic pain and the emotional brain; specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain[J] . J Neurosci, 2006,26(47) :2165-73.
  • 5Kim E, Choi CB, Kang C, et al. Adverse events in analgesic treatment with tramadol associated with CYP2D6 extensive- metaboliser and OPRM1 high-expression variants [J]. AnnRheum Dis, 2010,69(10) : 1889-1890.
  • 6Rollason V, Samer C, Piguet V, et al. Pharmacogenetics of analgesics: toward the individualization of prescription[J]. Pharmacogenomics, 2008,9(7) : 905-933.
  • 7De Cosmo G, Congedo E, Lai C, et al. Preoperative psycho- logic and demographic predictors of pain perception and tram- ado[ consumption using intravenous patient-controlled analge- sia[J] . Clin J Pain, 2008,24(5) : 399-405.
  • 8Ip HY, Abrishami A, Peng PW, et al. Predictors of Postop- erative Pain and Analgesic Consumption: A Qualitative Sys tematie Review[J]. Anesthesiology, 2009, 111 (3) : 657-677.
  • 9Leresche L. Defining Gender Disparities in Pain Management [[7. Clin OrthoD and Relat Res, 2011,469(7), 1871-1877.
  • 10Slanar O, Dupal P, Matouskova O, et al. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms[J] . Bratisl Lek Listy, 2012, 113 (3) : 152 -155.

二级参考文献45

  • 1陶恩祥.细胞色素氧化酶P450ⅡD6多态性及其分子生物学进展[J].国外医学(遗传学分册),1996,19(4):180-182. 被引量:3
  • 2Sadee W, Dai Z. Pharmacogenetics/genomics and per- sonalized medicine [J]. Hum Mol Gene, 2005, 14(suppl 2): 207-14.
  • 3Stamer UM, Lehnen K, Hothker F, et al. Impact of CYP2D6 genotype on postoperative tramado! analgesia [J]. Pain, 2003, 105(1-2): 231-8.
  • 4Hailing J, Weihe P, Brosen K. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients[J]. Ther Drug Monit, 2008, 30(3): 271-5.
  • 5Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I [J]. Clin Phar- macokinet, 2009, 48(11): 689-723.
  • 6Johansson I, Yue QY, Dahl ML, et al. Genetic analysis of the inerethnic difference between Chinese and Cau- casian in the polymorphic metabolism of debrisoquine and codine[J]. Eur J Pharmacol, 1991, 40(6): 553-6.
  • 7Gough AC, Miles JS, Spurr NK, et al. Identification of the primary gene defect at the cytochrome P450 CYP2D locus[J]. Nature, 1990, 347(6295): 773-6.
  • 8Desmeules JA, Piguet V, Collart, et al. Contribution of monoaminergic modulation to the analgesic effect of tramadol[J]. Br J Clin Phamacol, 1996, 41(1): 7-12.
  • 9Wenerholm A, .lohansson I, Massele AY, et al. De- creased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype[J]. Pharmacogenetics, 1999, 9(6): 707-14.
  • 10Johansson I, Oscarson M, Yue QY, et al. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoqune hy- droxylation[J]. Mol Pharmacol, 1994, 46(3): 452-9.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部